Company Intelligence
Merck
MedTwenty Company Score 85Pharmaceuticals · Rahway, United States · Founded 1891
Global pharmaceutical company, first to market with an oral PCSK9 inhibitor following FDA approval of Lipfendra.
Key facts
Employees72,000
Revenue$64.2bn (FY2025)
ValuationNot disclosed
Last roundListed
Funding history
| Date | Round | Amount | Lead investor |
|---|
Timeline
- 26 Sep 2026Lipfendra approved by FDA as first oral PCSK9 inhibitor.
Benchmarks, competitor comparison and export
Professional membership unlocks side-by-side competitor comparison, historical financial series and CSV export for this company.
Upgrade